Literature DB >> 18032737

Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit.

Richard Milner1, Stephanie Hung, Xiaoyun Wang, Greta I Berg, Maria Spatz, Gregory J del Zoppo.   

Abstract

BACKGROUND AND
PURPOSE: Apposition of endothelial cells and astrocyte foot processes to the basal lamina matrix is postulated to underlie the cerebral microvessel permeability barrier. Focal cerebral ischemia induces rapid loss of select matrix-binding integrins from both cell compartments in the nonhuman primate. This study is the first to examine the conditions underlying integrin loss from these cell-types during ischemia in vitro and their relation to the changes in vivo.
METHODS: The impact of normoxia or standardized oxygen-glucose deprivation on integrin expression by murine primary cerebral endothelial cells and astrocytes grown on matrix substrates (collagen IV, laminin, and perlecan) of the basal lamina were quantitatively assessed by flow cytometry.
RESULTS: Endothelial cell expression of the beta1 and alpha 5 subunits significantly increased on all matrix ligands, whereas astrocytes displayed modest significant decreases in alpha 5 and alpha 6 subunits. Oxygen-glucose deprivation produced a further significant increase in subunit beta1 expression by both cell types, but a clear decrease in both alpha1 and alpha 6 subunits by murine astrocytes.
CONCLUSIONS: Ischemia in vitro significantly increased endothelial cell beta1 expression, which is consistent with the increase in beta1 transcription by microvessels peripheral to the ischemic core. The loss of alpha1 and alpha 6 integrins from murine astrocytes is identical to that seen in the nonhuman primate in vivo. These findings establish both isolated murine cerebral endothelial cells and astrocytes as potential integrin response cognates of microvascular cells of the neurovascular unit in primates, and allow determination of the mechanisms of their changes to ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032737      PMCID: PMC2588548          DOI: 10.1161/STROKEAHA.107.486134

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  40 in total

Review 1.  Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier.

Authors:  J D Huber; R D Egleton; T P Davis
Journal:  Trends Neurosci       Date:  2001-12       Impact factor: 13.837

2.  Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 3.  Development of the blood-brain barrier.

Authors:  Britta Engelhardt
Journal:  Cell Tissue Res       Date:  2003-09-04       Impact factor: 5.249

4.  The extracellular matrix and cytokines regulate microglial integrin expression and activation.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

5.  Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1.

Authors:  S Fischer; M Wobben; H H Marti; D Renz; W Schaper
Journal:  Microvasc Res       Date:  2002-01       Impact factor: 3.514

6.  Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat.

Authors:  Gerhard F Hamann; Martin Liebetrau; Helge Martens; Dorothe Burggraf; Christian U A Kloss; Gundula Bültemeier; Natalie Wunderlich; Gabriele Jäger; Thomas Pfefferkorn
Journal:  J Cereb Blood Flow Metab       Date:  2002-05       Impact factor: 6.200

7.  Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates.

Authors:  Tetsufumi Koike; Naoko Kimura; Keiko Miyazaki; Tomonori Yabuta; Kensuke Kumamoto; Seiichi Takenoshita; Jian Chen; Masanobu Kobayashi; Masuo Hosokawa; Akiyoshi Taniguchi; Tetsuhito Kojima; Nobuhiro Ishida; Masao Kawakita; Harumi Yamamoto; Hiromu Takematsu; Akemi Suzuki; Yasunori Kozutsumi; Reiji Kannagi; Reiji Kanangi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

8.  Focal cerebral ischemia induces active proteases that degrade microvascular matrix.

Authors:  Shunichi Fukuda; Catherine A Fini; Takuma Mabuchi; James A Koziol; Leonard L Eggleston; Gregory J del Zoppo
Journal:  Stroke       Date:  2004-03-04       Impact factor: 7.914

Review 9.  Blood-brain barrier drug targeting: the future of brain drug development.

Authors:  William M Pardridge
Journal:  Mol Interv       Date:  2003-03

10.  Distinct roles for astrocyte alphavbeta5 and alphavbeta8 integrins in adhesion and migration.

Authors:  R Milner; X Huang; J Wu; S Nishimura; R Pytela; D Sheppard; C ffrench-Constant
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

View more
  64 in total

Review 1.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

2.  An angiogenic role for the α5β1 integrin in promoting endothelial cell proliferation during cerebral hypoxia.

Authors:  Longxuan Li; Jennifer Welser-Alves; Arjan van der Flier; Amin Boroujerdi; Richard O Hynes; Richard Milner
Journal:  Exp Neurol       Date:  2012-06-18       Impact factor: 5.330

3.  Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue.

Authors:  Michael P Kahle; Boyeon Lee; Tony Pourmohamad; Austin Cunningham; Hua Su; Helen Kim; Yongmei Chen; Charles E McCulloch; Nicholas M Barbaro; Michael T Lawton; William L Young; Gregory J Bix
Journal:  Neuroreport       Date:  2012-07-11       Impact factor: 1.837

Review 4.  The neurovascular unit in the setting of stroke.

Authors:  G J del Zoppo
Journal:  J Intern Med       Date:  2010-02       Impact factor: 8.989

5.  Dabigatran abrogates brain endothelial cell permeability in response to thrombin.

Authors:  Brian Thomas Hawkins; Yu-Huan Gu; Yoshikane Izawa; Gregory John del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

6.  Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression.

Authors:  Longxuan Li; Jennifer V Welser; Richard Milner
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

7.  Perlecan domain V is neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice.

Authors:  Gregory J Bix; Emma K Gowing; Andrew N Clarkson
Journal:  Transl Stroke Res       Date:  2013-06-07       Impact factor: 6.829

8.  The role of integrin alpha(v)beta (8) in neonatal hypoxic-ischemic brain injury.

Authors:  Jinhui Li; Yi Qu; Xihong Li; Deyuan Li; Fengyan Zhao; Meng Mao; Donna Ferriero; Dezhi Mu
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

9.  Acetylcholinesterase inhibition ameliorates retinal neovascularization and glial activation in oxygen-induced retinopathy.

Authors:  Qiu-Ping Liu; Xian Zhang; Ya-Zhou Qin; Jing-Lin Yi; Jing-Ming Li
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

Review 10.  Inflammation and the neurovascular unit in the setting of focal cerebral ischemia.

Authors:  G J del Zoppo
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.